These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 1705172)

  • 1. Monoclonal antibody PD41 recognizes an antigen restricted to prostate adenocarcinomas.
    Beckett ML; Lipford GB; Haley CL; Schellhammer PF; Wright GL
    Cancer Res; 1991 Feb; 51(4):1326-33. PubMed ID: 1705172
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunohistochemical localization of prostate carcinoma-associated antigens.
    Wright GL; Beckett ML; Starling JJ; Schellhammer PF; Sieg SM; Ladaga LE; Poleskic S
    Cancer Res; 1983 Nov; 43(11):5509-16. PubMed ID: 6193873
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [A monoclonal antibody that reacts with an antigen on both normal and malignant prostate cells].
    Dou L; Yu L; Xing N; Ding Y; Deng F; Guo Y
    Zhonghua Wai Ke Za Zhi; 1998 Apr; 36(4):234-6, 44. PubMed ID: 11825376
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Monoclonal antibodies to human prostate and bladder tumor-associated antigens.
    Starling JJ; Sieg SM; Beckett ML; Schellhammer PF; Ladaga LE; Wright GL
    Cancer Res; 1982 Aug; 42(8):3084-9. PubMed ID: 7046915
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The role of P501S and PSA in the diagnosis of metastatic adenocarcinoma of the prostate.
    Sheridan T; Herawi M; Epstein JI; Illei PB
    Am J Surg Pathol; 2007 Sep; 31(9):1351-5. PubMed ID: 17721190
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reactivity of monoclonal antibody DF3 with a high molecular weight antigen expressed in human ovarian carcinomas.
    Friedman EL; Hayes DF; Kufe DW
    Cancer Res; 1986 Oct; 46(10):5189-94. PubMed ID: 3530435
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Monoclonal antibody recognizing a carcinoembryonic antigen epitope differentially expressed in human colonic carcinoma versus normal adult colon tissues.
    Zhang HZ; Ordonez NG; Batsakis JG; Chan JC
    Cancer Res; 1989 Oct; 49(20):5766-73. PubMed ID: 2477148
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Human prostate tissue antigens defined by murine monoclonal antibodies.
    Starling JJ; Sieg SM; Beckett ML; Wirth PR; Wahab Z; Schellhammer PF; Ladaga LE; Poleskic S; Wright GL
    Cancer Res; 1986 Jan; 46(1):367-74. PubMed ID: 2415250
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization of a monoclonal antibody, KR-P8, that detects a new prostate-specific marker.
    Raynor RH; Hazra TA; Moncure CW; Mohanakumar T
    J Natl Cancer Inst; 1984 Sep; 73(3):617-25. PubMed ID: 6206270
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adjunct to the diagnostic distinction between adenocarcinomas of the ovary and the colon utilizing a monoclonal antibody (COL-4) with restricted carcinoembryonic antigen reactivity.
    Thor A; Muraro R; Gorstein F; Ohuchi N; Viglione M; Szpak CA; Johnston WW; Schlom J
    Cancer Res; 1987 Jan; 47(2):505-12. PubMed ID: 2431771
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunohistochemical characterization of two monoclonal antibodies, P25.48 and P25.91, which define a new prostate-specific antigen.
    Bazinet M; Cote RJ; Cordon-Cardo C; Myc A; Fair WR; Old LJ
    Cancer Res; 1988 Dec; 48(23):6938-42. PubMed ID: 2460231
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunohistochemical and pharmacokinetic characterization of the site-specific immunoconjugate CYT-356 derived from antiprostate monoclonal antibody 7E11-C5.
    Lopes AD; Davis WL; Rosenstraus MJ; Uveges AJ; Gilman SC
    Cancer Res; 1990 Oct; 50(19):6423-9. PubMed ID: 1698122
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prostate cancer-associated markers.
    Chu TM
    Immunol Ser; 1990; 53():339-56. PubMed ID: 1713065
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization of a prostate carcinoma mucin-like antigen (PMA).
    Beckett ML; Wright GL
    Int J Cancer; 1995 Sep; 62(6):703-10. PubMed ID: 7558418
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reactivity of monoclonal antibody F36/22 with human ovarian adenocarcinomas.
    Croghan GA; Wingate MB; Gamarra M; Johnson E; Chu TM; Allen H; Valenzuela L; Tsukada Y; Papsidero LD
    Cancer Res; 1984 May; 44(5):1954-62. PubMed ID: 6370421
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Disulfide bonding of a human prostate tumor-associated membrane antigen recognized by monoclonal antibody D83.21.
    Starling JJ; Wright GL
    Cancer Res; 1985 Feb; 45(2):804-8. PubMed ID: 2578309
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Monoclonal antibody identification and characterization of a Mr 43,000 membrane glycoprotein associated with human breast cancer.
    Edwards DP; Grzyb KT; Dressler LG; Mansel RE; Zava DT; Sledge GW; McGuire WL
    Cancer Res; 1986 Mar; 46(3):1306-17. PubMed ID: 3510721
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Applications of monoclonal antibodies in clinical cytology as exemplified by studies with monoclonal antibody B72.3. The George N. Papanicolaou award lecture.
    Johnston WW
    Acta Cytol; 1987; 31(5):537-56. PubMed ID: 3314301
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Monoclonal antibodies to a new antigenic marker in epithelial prostatic cells and serum of prostatic cancer patients.
    Horoszewicz JS; Kawinski E; Murphy GP
    Anticancer Res; 1987; 7(5B):927-35. PubMed ID: 2449118
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A novel monoclonal antibody (7B10) with differential reactivity between human mammary carcinoma and normal breast.
    Pancino G; Charpin C; Calvo F; Guillemin MC; Roseto A
    Cancer Res; 1987 Aug; 47(16):4444-52. PubMed ID: 3607774
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.